首页 | 本学科首页   官方微博 | 高级检索  
     

和厚朴酚通过UbcH8诱导AML1-ETO蛋白降解
引用本文:李海英,周斌,吴建波,邢冲云. 和厚朴酚通过UbcH8诱导AML1-ETO蛋白降解[J]. 温州医科大学学报, 2019, 49(5): 327-332
作者姓名:李海英  周斌  吴建波  邢冲云
作者单位:温州医科大学附属第一医院,浙江温州325015,1.中心实验室;2.血液内科
基金项目:国家自然科学基金青年基金资助项目(81501809)。
摘    要:
目的:研究和厚朴酚诱导AML1-ETO蛋白降解的可能机制。方法:用10、20、40 μmol/L的和厚朴酚处理Kasumi-1细胞,分别在24 h和48 h后qRT-PCR检测AML1-ETO、UbcH8 mRNA的表达;Western blot法检测蛋白表达;40 μmol/L和厚朴酚处理24 h,基因芯片分析寻找靶基因;构建UbcH8过表达质粒,通过反转录病毒转染Kasumi-1细胞,检测AML1-ETO蛋白;通过短发夹RNA(shRNA)敲除UbcH8的表达,40 μmol/L和厚朴酚处理48 h,同时检测AML1-ETO和UbcH8蛋白;构建异种移植小鼠模型,和厚朴酚处理,检测肿瘤的成瘤性和相关蛋白表达。结果:和厚朴酚减少Kasumi-1细胞中AML1-ETO蛋白的表达,并具有浓度和时间依赖性,但没有影响AML1-ETO mRNA的表达;和厚朴酚处理后的AML1-ETO蛋白稳定性降低;基因芯片分析发现,和厚朴酚将UbcH8 mRNA的表达提高了约4倍;和厚朴酚处理后,Kasumi-1细胞中的UbcH8 mRNA和蛋白的表达量均升高;过表达UbcH8的Kasumi-1细胞中,AML1-ETO蛋白表达量减少;用和厚朴酚处理UbcH8敲除后的Kasumi-1细胞,AML1-ETO的降解被阻断;和厚朴酚抑制了异种移植小鼠模型的肿瘤生长,肿瘤中的AML1-ETO蛋白显著降低,而UBCH8表达升高。结论:和厚朴酚能通过UbcH8降解白血病细胞中的AML1-ETO蛋白。

关 键 词:和厚朴酚  AML1-ETO  UbcH8  白血病  
收稿时间:2019-01-30

Honokiol-induced degradation of AML1-ETO oncoprotein through upregulation of UbcH8 in acute myeloid leukemia
LI Haiying,ZHOU Bin,WU Jianbo,XING Chongyun.. Honokiol-induced degradation of AML1-ETO oncoprotein through upregulation of UbcH8 in acute myeloid leukemia[J]. JOURNAL OF WENZHOU MEDICAL UNIVERSITY, 2019, 49(5): 327-332
Authors:LI Haiying  ZHOU Bin  WU Jianbo  XING Chongyun.
Affiliation:1.Laboratory of Internal Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China; 2.Department of Hematology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China
Abstract:
Objective: To investigate the possible mechanism of the degradation of AML1-ETO protein induced by honokiol. Methods: Kasumi-1 cells were treated with 10, 20 and 40 μmol/L honokiol for 24 h and 48 h. The mRNA expression of AML1-ETO and UbcH8 and the protein expression were detected by qRT-PCR and Western blot respectively. Microarry analysis was used to select the target gene. To explore the role of UbcH8 in the degradation of AML1-ETO protein induced by honokiol, the expression of UbcH8 was knocked down by small hairpin RNAs (shRNAs) and overexpressed by MSCV-based vector to detect the related indicators. A xenograft mice model was treated by honokiol to detect tumorigenicity and related protein expression. Results: Honokiol decreased the protein expression of AML1-ETO in a time- and concentration- dependent manner, and reduced the stability of AML1-ETO protein, but did not affect the mRNA expression of AML1-ETO in kasumi-1 cell. We identified UbcH8 as the target gene by honokiol through microarray analysis. Honokiol obviously increased the expression of UbcH8 by 4-fold. Furthermore, overexpression of UbcH8 decreased the expression of AML1-ETO and knockdown of UbcH8 by shRNAs prevented honokiol-induced degradation of AML-ETO, suggesting that UbcH8 plays a critical role in the degradation of AML1-ETO by honokiol. Finally, honokiol decreased xenograft tumor size in a xenograft leukemia mouse model. Meanwhile, the protein of AML1-ETO was significantly reduced, while UBCH8 expression was elevated. Conclusion: Honokiol can degrade AML1-ETO oncoprotein through upregulation of UbcH8 in acute myeloid leukemia.
Keywords:honokiol  AML1-ETO  UbcH8  leukemia  
点击此处可从《温州医科大学学报》浏览原始摘要信息
点击此处可从《温州医科大学学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号